Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOXAGAST: Perioperative nab-paclitaxel + FOLFOX in Oesogastric Adenocarcinoma
NCT02486601Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Jun 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in Esophago-Gastric Adenocarcinoma, sponsored by GERCOR. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
Esophago-Gastric Adenocarcinoma
Beyond the preview
Go deeper on NCT02486601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486601.